Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Arerugi = [Allergy]|March 20, 2018
[EFFICACY, PHARMACOKINETICS, AND SAFETY OF ICATIBANT FOR THE TREATMENT OF JAPANESE PATIENTS WITH AN ACUTE ATTACK OF HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY]Michihiro Hide, Atsushi Fukunaga, Junichi Maehara, et al.
Trials|January 8, 2020
Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trialAtsushi Fukunaga, Yoshiko Oda, Ken Washio, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|November 2, 2019
Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label studyMichihiro Hide, Atsushi Fukunaga, Junichi Maehara, et al.
Rinsho Shinkeigaku = Clinical Neurology|February 28, 2007
[Adult onset Langerhans cell histiocytosis with progressive cerebellar ataxia and spastic paraparesis]Hiroshi Kobessho, Atsushi Fukunaga, Shigeru Mitsui, et al.
Signal Transduction and Targeted Therapy|October 28, 2020
Progress in the mechanism and targeted drug therapy for COPDCuixue Wang, Jiedong Zhou, Jinquan Wang, et al.
The Journal of Dermatology|March 30, 2022
Lower efficacy of omalizumab in older adults with chronic spontaneous urticariaRikuma Kitao, Yoshiko Oda, Ken Washio, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|March 3, 2011
Rapid desensitization with autologous sweat in cholinergic urticariaTakeshi Kozaru, Atsushi Fukunaga, Kumiko Taguchi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 22, 2022
Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance studyMichihiro Hide, Atsushi Fukunaga, Takayuki Suzuki, et al.
American Journal of Clinical Dermatology|July 27, 2025
Use of the Rash Appearance to Distinguish Cholinergic Urticaria Subtypes: A Retrospective Cohort StudyM Nagai, T Fukumoto, S Imamura, et al.
Frontiers in Medicine|March 4, 2024
Solar urticaria: clinical characteristics, treatment effectiveness, long-term prognosis, and QOL status in 29 patientsShinya Imamura, Yoshiko Oda, Takeshi Fukumoto, et al.
Pageof 15